Live Yum Brands Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Cosmos Health Inc.

Get SEC filing alerts via email and in your feed for Cosmos Health Inc.

COSM

Cosmos Health Inc.

About Cosmos Health Inc.

Cosmos Health Inc. is a diversified global healthcare company specializing in the development, manufacturing, and distribution of pharmaceutical and nutraceutical products. Its core segments include generic medicines, innovative drugs, nutraceuticals, biocides, medical devices, and telehealth services. The company leverages proprietary brands, research & development, and strategic partnerships to serve markets across Europe and beyond, emphasizing innovation, cost-efficiency, and a vertically integrated business model.
This description was generated via AI from an annual report. Updated 10 months ago.

Latest SEC Filings from Cosmos Health Inc.

1
1
Cosmos Health Inc. Cosmos Health Inc. Reports 30.7% Revenue Growth but Wider Net Loss in Q1 2026

Via official filing (AI summary) | 2 months ago | 0 comments

2
1
Cosmos Health Inc. Cosmos Health Inc. Reports $19.1 Million Net Loss Despite 19.9% Revenue Growth in 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Cosmos Health Inc. Cosmos Health Reports 37.8% Revenue Growth but Incurred $5.4 Million Net Loss in Q3 2025

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
Cosmos Health Inc. Cosmos Health Inc. Reports Q2 2025 Revenue Growth of 11.7% to $14.7 Million

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
Cosmos Health Inc. Cosmos Health Inc. Reports Q1 2025 Financial Results with Revenue of $13.7M and Improved Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Cosmos Health Inc. Cosmos Health Reports 7.1% Revenue Growth, Net Loss in Nine Months Ended September 30, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments